NCT06485219 2026-02-06
A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2 Active not recruiting
Chengdu Zenitar Biomedical Technology Co., Ltd
Kyowa Kirin Co., Ltd.
Bio-Path Holdings, Inc.
Daiichi Sankyo